Assertio Finalizes Merger with Zydus Lifesciences and Delists from Nasdaq
LAKE FOREST, Ill., June 16, 2026 Assertio Holdings, Inc. announced the successful completion of its previously announced merger with...
Zydus Lifesciences
Advertisement
FDA Grants Priority Review to Zydus Therapeutics’ Saroglitazar for Rare Liver Disease
PENNINGTON, New Jersey and AHMEDABAD, India, May 28, 2026 Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences, has...
Zydus Therapeutics Reports Positive Topline Results from EPICS-III Trial of Saroglitazar Magnesium in Primary Biliary Cholangitis
Zydus Therapeutics, Inc., a U.S.-based innovation arm of Zydus Lifesciences Ltd., today announced positive topline data from its pivotal...
Advertisement
